- Home
- FRPH vs ETON Comparison
FRPH vs ETON Comparison
Compare FRPH & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- ETON
- Stock Information
- Founded
- FRPH 1986
- ETON 2017
- Country
- FRPH United States
- ETON United States
- Employees
- FRPH N/A
- ETON N/A
- Industry
- FRPH Real Estate
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- ETON Health Care
- Exchange
- FRPH Nasdaq
- ETON Nasdaq
- Market Cap
- FRPH 482.5M
- ETON 388.3M
- IPO Year
- FRPH N/A
- ETON 2018
- Fundamental
- Price
- FRPH $24.21
- ETON $20.26
- Analyst Decision
- FRPH
- ETON Strong Buy
- Analyst Count
- FRPH 0
- ETON 3
- Target Price
- FRPH N/A
- ETON $29.67
- AVG Volume (30 Days)
- FRPH 59.4K
- ETON 337.5K
- Earning Date
- FRPH 11-05-2025
- ETON 11-11-2025
- Dividend Yield
- FRPH N/A
- ETON N/A
- EPS Growth
- FRPH N/A
- ETON N/A
- EPS
- FRPH 0.28
- ETON N/A
- Revenue
- FRPH $32,293,999.00
- ETON $58,181,000.00
- Revenue This Year
- FRPH N/A
- ETON $105.25
- Revenue Next Year
- FRPH N/A
- ETON $40.84
- P/E Ratio
- FRPH $86.44
- ETON N/A
- Revenue Growth
- FRPH 3.18
- ETON 85.40
- 52 Week Low
- FRPH $23.52
- ETON $6.00
- 52 Week High
- FRPH $33.00
- ETON $23.00
- Technical
- Relative Strength Index (RSI)
- FRPH 39.29
- ETON 59.96
- Support Level
- FRPH $23.52
- ETON $19.48
- Resistance Level
- FRPH $24.48
- ETON $23.00
- Average True Range (ATR)
- FRPH 0.49
- ETON 1.08
- MACD
- FRPH -0.01
- ETON -0.01
- Stochastic Oscillator
- FRPH 35.03
- ETON 50.72
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.